Sun Pharma.Inds.

Part of MojoOne Strategy
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE044A01036
  • NSEID: SUNPHARMA
  • BSEID: 524715
INR
1,702.80
73.9 (4.54%)
BSENSE

Feb 03

BSE+NSE Vol: 87.92 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
15,520.54
14,478.31
13,851.40
12,958.84
13,675.46
13,291.39
12,652.75
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
15,520.54
14,478.31
13,851.40
12,958.84
13,675.46
13,291.39
12,652.75
Raw Material Cost
1,813.48
1,621.51
1,771.59
1,845.06
1,408.31
1,638.72
1,557.01
Purchase of Finished goods
922.42
1,087.79
1,047.98
1,036.73
1,238.69
875.10
997.43
(Increase) / Decrease In Stocks
209.20
273.43
-4.81
-244.60
93.54
180.38
120.99
Employee Cost
2,892.00
2,764.79
2,801.66
2,488.52
2,552.28
2,477.70
2,454.62
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
4,734.95
4,203.74
3,933.32
4,117.04
4,373.62
4,180.53
3,915.08
Total Expenditure (Excl Depreciation)
10,572.05
9,951.26
9,549.74
9,242.75
9,666.44
9,352.43
9,045.13
Operating Profit (PBDIT) excl Other Income
4,948.49
4,527.05
4,301.66
3,716.09
4,009.02
3,938.96
3,607.62
Other Income
578.84
469.92
464.46
612.87
465.62
354.00
532.55
Operating Profit (PBDIT)
5,527.33
4,996.97
4,766.12
4,328.96
4,474.64
4,292.96
4,140.17
Interest
78.36
99.86
74.80
49.14
51.51
69.17
61.54
Exceptional Items
-489.48
0.00
-818.00
-361.68
-316.17
0.00
0.00
Gross Profit (PBDT)
4,959.49
4,897.11
3,873.32
3,918.14
4,106.96
4,223.79
4,078.63
Depreciation
732.33
729.50
700.55
663.79
630.56
625.91
655.13
Profit Before Tax
4,227.16
4,167.61
3,172.77
3,254.35
3,476.40
3,597.88
3,423.50
Tax
826.07
1,030.52
870.15
1,093.71
558.86
567.21
552.25
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3,401.09
3,137.09
2,302.62
2,160.64
2,917.54
3,030.67
2,871.25
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
3,401.09
3,137.09
2,302.62
2,160.64
2,917.54
3,030.67
2,871.25
Share in Profit of Associates
-19.92
-12.14
-9.75
-6.71
-4.56
6.66
-10.74
Minority Interest
12.36
7.00
14.24
4.05
9.60
-2.83
24.89
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3,368.81
3,117.95
2,278.63
2,149.88
2,903.38
3,040.16
2,835.62
Equity Capital
239.93
239.93
239.93
239.93
239.93
239.93
239.93
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
14.04
13.0
9.5
8.96
12.1
12.67
11.82
Diluted Earnings per share
14.0
13.0
9.5
9.0
12.1
12.7
11.8
Operating Profit Margin (Excl OI)
31.99%
31.43%
31.2%
29.0%
29.84%
29.7%
28.8%
Gross Profit Margin
32.06%
34.0%
28.1%
30.57%
30.56%
31.84%
32.57%
PAT Margin
21.99%
21.78%
16.7%
16.86%
21.71%
22.85%
22.93%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 7.20% vs 4.53% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 8.05% vs 36.83% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 9.31% vs 5.24% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -21.53% vs 33.50% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Sun Pharma.Inds. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
15,520.54
2,715.00
12,805.54
471.66%
Other Operating Income
0.00
0.00
0.00
Total Operating income
15,520.54
2,715.00
12,805.54
471.66%
Raw Material Cost
1,813.48
937.00
876.48
93.54%
Purchase of Finished goods
922.42
0.00
922.42
(Increase) / Decrease In Stocks
209.20
136.00
73.20
53.82%
Employee Cost
2,892.00
354.00
2,538.00
716.95%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
4,734.95
400.00
4,334.95
1,083.74%
Total Expenditure (Excl Depreciation)
10,572.05
1,827.00
8,745.05
478.66%
Operating Profit (PBDIT) excl Other Income
4,948.49
888.00
4,060.49
457.26%
Other Income
578.84
145.00
433.84
299.20%
Operating Profit (PBDIT)
5,527.33
1,033.00
4,494.33
435.08%
Interest
78.36
8.00
70.36
879.50%
Exceptional Items
-489.48
0.00
-489.48
Gross Profit (PBDT)
4,959.49
1,025.00
3,934.49
383.85%
Depreciation
732.33
113.00
619.33
548.08%
Profit Before Tax
4,227.16
912.00
3,315.16
363.50%
Tax
826.07
223.00
603.07
270.43%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
3,401.09
689.00
2,712.09
393.63%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
3,401.09
689.00
2,712.09
393.63%
Share in Profit of Associates
-19.92
0.00
-19.92
Minority Interest
12.36
0.00
12.36
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3,368.81
689.00
2,679.81
388.94%
Equity Capital
239.93
53.00
186.93
352.70%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
14.04
26.00
-11.96
-46.00%
Diluted Earnings per share
14.00
25.97
-11.97
-46.09%
Operating Profit Margin (Excl OI)
31.99%
32.71%
0.00
-0.72%
Gross Profit Margin
32.06%
37.75%
0.00
-5.69%
PAT Margin
21.99%
25.38%
0.00
-3.39%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 15,520.54 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 7.20% vs 4.53% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 13.49% vs 10.46% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3,368.81 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 8.05% vs 36.83% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 16.03% vs 15.04% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4,948.49 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 9.31% vs 5.24% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 23.43% vs 15.31% in Dec 2024

Quarterly - Interest
Interest 78.36 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -21.53% vs 33.50% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 52.13% vs 48.32% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.99%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support@mojoinfinity.com, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."